JPH0362696B2 - - Google Patents

Info

Publication number
JPH0362696B2
JPH0362696B2 JP59220565A JP22056584A JPH0362696B2 JP H0362696 B2 JPH0362696 B2 JP H0362696B2 JP 59220565 A JP59220565 A JP 59220565A JP 22056584 A JP22056584 A JP 22056584A JP H0362696 B2 JPH0362696 B2 JP H0362696B2
Authority
JP
Japan
Prior art keywords
liposome
liposome preparation
preparation according
arachidonic acid
freeze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59220565A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61100518A (ja
Inventor
Jun Mizutani
Seiji Shioda
Mitsuharu Inaba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP59220565A priority Critical patent/JPS61100518A/ja
Publication of JPS61100518A publication Critical patent/JPS61100518A/ja
Publication of JPH0362696B2 publication Critical patent/JPH0362696B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59220565A 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤 Granted JPS61100518A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59220565A JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59220565A JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Publications (2)

Publication Number Publication Date
JPS61100518A JPS61100518A (ja) 1986-05-19
JPH0362696B2 true JPH0362696B2 (en, 2012) 1991-09-26

Family

ID=16752979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59220565A Granted JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Country Status (1)

Country Link
JP (1) JPS61100518A (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
JP2780755B2 (ja) * 1987-05-22 1998-07-30 ザ リポソーム カンパニー，インコーポレイテッド プロスタグランジン‐脂質製剤
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
JP2599390B2 (ja) * 1987-06-25 1997-04-09 第一製薬株式会社 安定なリポソーム水分散液
JP2550352B2 (ja) * 1987-06-26 1996-11-06 第一製薬株式会社 リポソ−ム製剤
JPH04356421A (ja) * 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
DE4309579C3 (de) * 1993-03-24 2000-01-27 Sanol Arznei Schwarz Gmbh Pharmazeutische Zusammensetzung in Form einer Packung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations

Also Published As

Publication number Publication date
JPS61100518A (ja) 1986-05-19

Similar Documents

Publication Publication Date Title
KR890004689B1 (ko) 인지질 및 미셀 입자 중에서 피포시킨 안트라사이클린 항악성종양제
US5082664A (en) Prostaglandin-lipid formulations
US5262168A (en) Prostaglandin-lipid formulations
EP0004223B1 (fr) Procédé de fabrication de capsules lipidiques renfermant un matériau biologiquement actif, produits obtenus par ce procédé ainsi que leur utilisation
JP3676976B2 (ja) 多胞状リポソームへの薬剤封入量の調節
KR100387561B1 (ko) 활성제제의조절방출을위한다중소포성리포솜의제법
JPH0753661B2 (ja) プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
AU689479B2 (en) Fusogenic liposomes and methods of making and using same
HK1007496B (en) Prostaglandin-lipid formulations
US5576017A (en) Heterovesicular liposomes
JP2018502870A (ja) トラネキサム酸の多小胞リポソーム処方物
JPS6339810A (ja) リポソ−ムの製造法
US20010006648A1 (en) Liposomes and liposomal dispersion
CN104800171B (zh) 一种灯盏花素内相凝胶化多囊脂质体冻干粉及其制备方法
WO1996040061A1 (en) Method for encapsulating pharmaceutical materials
JP2014506918A (ja) 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物
JPH0362696B2 (en, 2012)
JPH07108166A (ja) リポソーム
CA2024804A1 (en) Prostaglandin-containing liposome preparations
RU2217128C1 (ru) Препарат для местного применения при лечении туберкулеза легких и гнойно-воспалительных заболеваний
US20060030578A1 (en) Pharmaceutically active lipid based formulation of irinotecan
JPH06502623A (ja) 安定なドキソルビシン／リポソーム組成物
JP2780755B2 (ja) プロスタグランジン‐脂質製剤
JPH04356421A (ja) プロスタグランジン類含有脂肪小体組成物
WO2013026989A2 (fr) Liposome comprenant au moins un derive de cholesterol